AT

Anjanamma Tirumalasetti

Active Director Director DIN 07673338
DIN 07673338 First appointment Dec 2016 Primary industry Non-Profit Organizations
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Anjanamma Tirumalasetti

Data last updated:

Anjanamma Tirumalasetti is a Director at Bramha Siddha Ayur Pharma & Research Centre Private Limited (since 2016). The company operates in Non-Profit Organizations.

DIN 07673338
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 27 Dec 2016
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Dec 20162016Active

Board colleagues of Anjanamma Tirumalasetti

Directorship timeline

Open interactive timeline →
Bramha Siddha Ayur Pharma & Research Centre Private Limited
Premium access

Shareholding and investment profile for Anjanamma Tirumalasetti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anjanamma Tirumalasetti

Anjanamma Tirumalasetti currently holds 1 directorship: Bramha Siddha Ayur Pharma & Research Centre Private Limited (Director, since 27 Dec 2016).

Anjanamma Tirumalasetti was first appointed on 27 Dec 2016 as Director at Bramha Siddha Ayur Pharma & Research Centre Private Limited.

The current boards of Anjanamma Tirumalasetti's companies include Guggilla Neeraja (Bramha Siddha Ayur Pharma & Research Centre Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available